文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer.

作者信息

Li Lingfei, Li Mingyang, Jia Qingge

机构信息

State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China.

State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China.

出版信息

Pathol Res Pract. 2023 Aug;248:154711. doi: 10.1016/j.prp.2023.154711. Epub 2023 Jul 23.


DOI:10.1016/j.prp.2023.154711
PMID:37494802
Abstract

Myeloid-derived suppressor cell (MDSC) mainly exists in tumor microenvironment (TME) and interferes with normal immune response of the body. These immature differentiated cells cooperate with tumor cells for immune escape and proliferation. The subtypes of MDSC are different in different organisms, and STAT become a high priority for the signaling pathway mediating the regulation of MDSC. The surface of MDSC cell population contains a variety of signal molecular receptors, and its differentiation degree is toilless to be chemotaxis by different factors. The role of MDSC in silencing T cells and promoting regulatory T cells (Treg) is particularly significant. This review mainly contains the origin of MDSC, the characteristics of subgroups, the focus of the study on MDSC heat molecules and signaling pathways, the relationship between MDSC and carcinoma, prognosis and hope to propose an overview of current MDSCs- targeting therapies so as to provide new ideas for cancer treatment.

摘要

相似文献

[1]
Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer.

Pathol Res Pract. 2023-8

[2]
Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.

Invest New Drugs. 2022-6

[3]
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

Adv Exp Med Biol. 2020

[4]
Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.

Cancer Lett. 2016-9-28

[5]
Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.

Front Immunol. 2023

[6]
Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.

Cells. 2020-4-18

[7]
Therapeutic prospects of targeting myeloid-derived suppressor cells and immune checkpoints in cancer.

Immunol Cell Biol. 2018-4-22

[8]
Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific.

Oncogene. 2021-1

[9]
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.

Front Immunol. 2020

[10]
Visualization and quantification of homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer.

Theranostics. 2019-8-12

引用本文的文献

[1]
Phosphorus-32 microspheres: A dual-modality transarterial radioembolization approach for hepatocellular carcinoma therapy and Anti-PD1 immunotherapy potentiation.

Mater Today Bio. 2025-8-16

[2]
Beyond borders: engineering organ-targeted immunotherapies to overcome site-specific barriers in cancer.

Drug Deliv Transl Res. 2025-8-11

[3]
Regulatory T cells suppress TLR9-induced formation of intrahepatic myeloid-cell aggregates for T cell population expansion in liver.

Med Microbiol Immunol. 2025-5-14

[4]
The synergistic antitumor effect of Karanahan technology and vaccination using anti-OX40 antibodies.

Oncol Res. 2025-4-18

[5]
Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs.

J Clin Invest. 2025-4-3

[6]
Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation.

Breast Cancer Res Treat. 2025-6

[7]
Editorial: Genetic and cellular heterogeneity in tumors.

Front Cell Dev Biol. 2024-12-9

[8]
Increased CD14HLA-DR myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome.

PeerJ. 2024

[9]
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review).

Med Int (Lond). 2024-6-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索